Retension Pharmaceuticals
PrivateLast Round
Series B
Aug 6, 2025
Total Funding Raised
$25.4M
Company Overview
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for the treatment of hypertension and other serious cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Retension Pharmaceuticals Comparables
Compare Retension Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mineralys Therapeutics | 78% | |
| Alnylam Pharmaceuticals | 71% | |
| Idorsia Ltd. | 71% |
Retension Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 6, 2025 | ||||
| Series A | Aug 21, 2024 |
Retension Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dais Partners | Series B |
| Collage Venture Partners | Series A, Series B |
| Transhuman Capital | Series B |
| Green Park & Golf Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 6, 2025
Raised $15M from Collage Venture Partners, Green Park & Golf Ventures, and others.
- Aug 21, 2024
$10.4M round led by Collage Venture Partners.
Recent news
Latest coverage and updates
- is_developingSep 18, 2026
Retension Pharmaceuticals Inc. is developing medicines to treat hypertension and other cardiovascular diseases.
- goes_publicSep 18, 2026
Retension Pharmaceuticals Inc. was planning to go public on Sep 18th '26.
Retension Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access